Skip to content

ViraxImmune™
Products
Services
Media
Leadership
Contact
Investor Relations

ViraxImmune™
Products
Services
Media
Leadership
Contact
Investor Relations

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

July 21 2022

View Our Press Release

BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire
ML1 5UH
United Kingdom

Quick links

Discover ViraxImmune™ Novel PAIS Diagnostic Development
Products
Custom Immunology Services By Virax Biolabs
Terms and Conditions
News And Media Updates From Virax Biolabs
Meet Virax Biolabs’ Leadership Team and Advisory Board
Contact
Investor Relations

Discover ViraxImmune™ Novel PAIS Diagnostic Development
Products
Custom Immunology Services By Virax Biolabs
Terms and Conditions
News And Media Updates From Virax Biolabs
Meet Virax Biolabs’ Leadership Team and Advisory Board
Contact
Investor Relations

Subscribe to Our Newsletter

Email

You can cancel subscription any time

Follow us

Facebook Twitter Linkedin Instagram

© All Rights Reserved, Virax Biolabs 2025 | Privacy Policy | Terms of Service